{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:53:58Z","timestamp":1794866038731,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["575466"],"award-info":[{"award-number":["575466"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000223","name":"Muscular Dystrophy Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-156379"],"award-info":[{"award-number":["PJT-156379"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1038\/s41434-022-00338-1","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T02:02:48Z","timestamp":1650852168000},"page":"544-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy"],"prefix":"10.1038","volume":"29","author":[{"given":"Aoife","family":"Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-1195","authenticated-orcid":false,"given":"Marc-Olivier","family":"Deguise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Beauvais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Yaworski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Thebault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4375-717X","authenticated-orcid":false,"given":"Vincent","family":"Tabard-Cossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Hensel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5485-8748","authenticated-orcid":false,"given":"Bernard L.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-7310","authenticated-orcid":false,"given":"Rashmi","family":"Kothary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"338_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33:831\u201346.","journal-title":"Neurol Clin."},{"key":"338_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, B\u00fcrglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365.","journal-title":"Cell."},{"key":"338_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldk\u00f6tter","year":"2002","unstructured":"Feldk\u00f6tter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70:358\u201368.","journal-title":"Am J Hum Genet."},{"key":"338_CR4","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8:1177\u201383.","journal-title":"Hum Mol Genet."},{"key":"338_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/hmg\/9.2.259","volume":"9","author":"CL Lorson","year":"2000","unstructured":"Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet. 2000;9:259\u201365.","journal-title":"Hum Mol Genet."},{"key":"338_CR6","unstructured":"Sumner CJ, Paushkin S, Ko C-P. Spinal muscular atrophy: disease mechanisms and therapy. Academic Press; 2016.508p."},{"key":"338_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-3-24","volume":"3","author":"JG Boyer","year":"2013","unstructured":"Boyer JG, Murray LM, Scott K, De Repentigny Y, Renaud J-M, Kothary R. Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy. Skelet Muscle. 2013;3:24.","journal-title":"Skelet Muscle."},{"key":"338_CR8","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1093\/hmg\/ddu142","volume":"23","author":"JG Boyer","year":"2014","unstructured":"Boyer JG, Deguise M-O, Murray LM, Yazdani A, De Repentigny Y, Boudreau-Larivi\u00e8re C, et al. Myogenic program dysregulation is contributory to disease pathogenesis in spinal muscular atrophy. Hum Mol Genet. 2014;23:4249\u201359.","journal-title":"Hum Mol Genet."},{"key":"338_CR9","doi-asserted-by":"publisher","first-page":"4745","DOI":"10.1093\/hmg\/ddu189","volume":"23","author":"KV Bricceno","year":"2014","unstructured":"Bricceno KV, Martinez T, Leikina E, Duguez S, Partridge TA, Chernomordik LV, et al. Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Hum Mol Genet. 2014;23:4745\u201357.","journal-title":"Hum Mol Genet."},{"key":"338_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/jmg.2008.057950","volume":"45","author":"S Rudnik-Sch\u00f6neborn","year":"2008","unstructured":"Rudnik-Sch\u00f6neborn S, Heller R, Berg C, Betzler C, Grimm T, Eggermann T, et al. Congenital heart disease is a feature of severe infantile spinal muscular atrophy. J Med Genet. 2008;45:635\u20138.","journal-title":"J Med Genet."},{"key":"338_CR11","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1093\/hmg\/ddq329","volume":"19","author":"M Shababi","year":"2010","unstructured":"Shababi M, Habibi J, Yang HT, Vale SM, Sewell WA, Lorson CL. Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum Mol Genet. 2010;19:4059\u201371.","journal-title":"Hum Mol Genet."},{"key":"338_CR12","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/acn3.50855","volume":"6","author":"M Deguise","year":"2019","unstructured":"Deguise M, Baranello G, Mastella C, Beauvais A, Michaud J, Leone A, et al. Abnormal fatty acid metabolism is a core component of spinal muscular atrophy. Ann Clin Transl Neurol. 2019;6:1519\u201332.","journal-title":"Ann Clin Transl Neurol."},{"key":"338_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ejpn.2012.01.004","volume":"16","author":"Z Zolkipli","year":"2012","unstructured":"Zolkipli Z, Sherlock M, Biggar WD, Taylor G, Hutchison JS, Peliowski A, et al. Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2012;16:549\u201353.","journal-title":"Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc."},{"key":"338_CR14","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/ana.23582","volume":"72","author":"M Bowerman","year":"2012","unstructured":"Bowerman M, Swoboda KJ, Michalski J-P, Wang G-S, Reeks C, Beauvais A, et al. Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann Neurol. 2012;72:256\u201368.","journal-title":"Ann Neurol"},{"key":"338_CR15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jpeds.2015.09.023","volume":"167","author":"RH Davis","year":"2015","unstructured":"Davis RH, Miller EA, Zhang RZ, Swoboda KJ. Responses to fasting and glucose loading in a cohort of well children with spinal muscular atrophy type II. J Pediatr. 2015;167:1362\u2013.e1.","journal-title":"J Pediatr"},{"key":"338_CR16","first-page":"801","volume":"26","author":"M-O Deguise","year":"2017","unstructured":"Deguise M-O, De Repentigny Y, McFall E, Auclair N, Sad S, Kothary R. Immune dysregulation may contribute to disease pathogenesis in spinal muscular atrophy mice. Hum Mol Genet. 2017;26:801\u201319.","journal-title":"Hum Mol Genet"},{"key":"338_CR17","first-page":"932","volume":"26","author":"M-T Khairallah","year":"2017","unstructured":"Khairallah M-T, Astroski J, Custer SK, Androphy EJ, Franklin CL, Lorson CL. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy. Hum Mol Genet. 2017;26:932\u201341.","journal-title":"Hum Mol Genet."},{"key":"338_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/joa.12546","volume":"230","author":"AK Thomson","year":"2017","unstructured":"Thomson AK, Somers E, Powis RA, Shorrock HK, Murphy K, Swoboda KJ, et al. Survival of motor neurone protein is required for normal postnatal development of the spleen. J Anat. 2017;230:337\u201346.","journal-title":"J Anat."},{"key":"338_CR19","doi-asserted-by":"publisher","first-page":"5665","DOI":"10.1093\/hmg\/ddv292","volume":"24","author":"SE Gombash","year":"2015","unstructured":"Gombash SE, Cowley CJ, Fitzgerald JA, Iyer CC, Fried D, McGovern VL, et al. SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum Mol Genet. 2015;24:5665.","journal-title":"Hum Mol Genet."},{"key":"338_CR20","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/0883073807305788","volume":"22","author":"CH Wang","year":"2007","unstructured":"Wang CH, Finkel RS, Bertini ES, Schroth M, Simonds A, Wong B, et al. Consensus statement for standard of care in spinal muscular atrophy. J Child Neurol. 2007;22:1027\u201349.","journal-title":"J Child Neurol."},{"key":"338_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/hmg\/ddq514","volume":"20","author":"E Dominguez","year":"2011","unstructured":"Dominguez E, Marais T, Chatauret N, Benkhelifa-Ziyyat S, Duque S, Ravassard P, et al. Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet. 2011;20:681\u201393.","journal-title":"Hum Mol Genet."},{"key":"338_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, et al. Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol. 2010;28:271\u20134.","journal-title":"Nat Biotechnol."},{"key":"338_CR23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N Engl J Med. 2017;377:1713\u201322.","journal-title":"N Engl J Med."},{"key":"338_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59\u201365.","journal-title":"Nat Biotechnol."},{"key":"338_CR25","unstructured":"Novartis Gene Therapies. Phase I, Open-Label, Dose Comparison Study of AVXS-101 for Sitting But Non-ambulatory Patients With Spinal Muscular Atrophy [Internet]. clinicaltrials.gov; 2021 Jun [cited 2021 Jul 22]. Report No.: NCT03381729. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03381729."},{"key":"338_CR26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.nmd.2011.09.007","volume":"22","author":"M Bowerman","year":"2012","unstructured":"Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Neuromuscul Disord NMD. 2012;22:263\u201376.","journal-title":"Neuromuscul Disord NMD."},{"key":"338_CR27","first-page":"4494","volume":"25","author":"M Eshraghi","year":"2016","unstructured":"Eshraghi M, McFall E, Gibeault S, Kothary R. Effect of genetic background on the phenotype of the Smn2B\/- mouse model of spinal muscular atrophy. Hum Mol Genet. 2016;25:4494\u2013506.","journal-title":"Hum Mol Genet."},{"key":"338_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jcmgh.2021.01.019","volume":"12","author":"M-O Deguise","year":"2021","unstructured":"Deguise M-O, Pileggi C, De Repentigny Y, Beauvais A, Tierney A, Chehade L, et al. SMN depleted mice offer a robust and rapid onset model of nonalcoholic fatty liver disease. Cell Mol Gastroenterol Hepatol. 2021;12:354\u2013.e3.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"338_CR29","doi-asserted-by":"publisher","first-page":"102750","DOI":"10.1016\/j.ebiom.2020.102750","volume":"55","author":"M-O Deguise","year":"2020","unstructured":"Deguise M-O, De Repentigny Y, Tierney A, Beauvais A, Michaud J, Chehade L, et al. Motor transmission defects with sex differences in a new mouse model of mild spinal muscular atrophy. EBioMedicine. 2020;55:102750.","journal-title":"EBioMedicine."},{"key":"338_CR30","first-page":"e51162","volume":"83","author":"L Murray","year":"2014","unstructured":"Murray L, Gillingwater TH, Kothary R. Dissection of the transversus abdominis muscle for whole-mount neuromuscular junction analysis. JoVE J Vis Exp. 2014;83:e51162.","journal-title":"JoVE J Vis Exp."},{"key":"338_CR31","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00415-019-09547-y","volume":"267","author":"CD Wurster","year":"2020","unstructured":"Wurster CD, Steinacker P, G\u00fcnther R, Koch JC, Lingor P, Uzelac Z, et al. Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen. J Neurol. 2020;267:36\u201344.","journal-title":"J Neurol."},{"key":"338_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/hmg\/ddm367","volume":"17","author":"LM Murray","year":"2008","unstructured":"Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet. 2008;17:949\u201362.","journal-title":"Hum Mol Genet."},{"key":"338_CR33","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1523\/JNEUROSCI.2208-10.2010","volume":"30","author":"G-H Park","year":"2010","unstructured":"Park G-H, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci. 2010;30:12005\u201319.","journal-title":"J Neurosci."},{"key":"338_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature10485","volume":"478","author":"Y Hua","year":"2011","unstructured":"Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, et al. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature. 2011;478:123\u20136.","journal-title":"Nature."},{"key":"338_CR35","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1101\/gad.256644.114","volume":"29","author":"Y Hua","year":"2015","unstructured":"Hua Y, Liu YH, Sahashi K, Rigo F, Bennett CF, Krainer AR. Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models. Genes Dev. 2015;29:288\u201397.","journal-title":"Genes Dev."},{"key":"338_CR36","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.ymthe.2020.05.011","volume":"28","author":"A Besse","year":"2020","unstructured":"Besse A, Astord S, Marais T, Roda M, Giroux B, Lejeune F-X, et al. AAV9-mediated expression of SMN restricted to neurons does not rescue the spinal muscular atrophy phenotype in mice. Mol Ther. 2020;28:1887\u2013901.","journal-title":"Mol Ther."},{"key":"338_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer K, Ferraiuolo L, Schmelzer L, Braun L, McGovern V, Likhite S, et al. Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose\u2013response study in mice and nonhuman primates. Mol Ther. 2015;23:477\u201387.","journal-title":"Mol Ther."},{"key":"338_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01414-8","volume":"15","author":"F Audic","year":"2020","unstructured":"Audic F, de la Banda MGG, Bernoux D, Ramirez-Garcia P, Durigneux J, Barnerias C, et al. Effects of nusinersen after one year of treatment in 123 children with SMA type 1 or 2: a French real-life observational study. Orphanet J Rare Dis. 2020;15:148.","journal-title":"Orphanet J Rare Dis."},{"key":"338_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ppul.25140","volume":"56","author":"M Lavie","year":"2021","unstructured":"Lavie M, Diamant N, Cahal M, Sadot E, Be\u2019er M, Fattal-Valevski A, et al. Nusinersen for spinal muscular atrophy type 1: Real-world respiratory experience. Pediatr Pulmonol. 2021;56:291\u20138.","journal-title":"Pediatr Pulmonol."},{"key":"338_CR40","doi-asserted-by":"publisher","first-page":"35ra42","DOI":"10.1126\/scitranslmed.3000830","volume":"2","author":"CF Valori","year":"2010","unstructured":"Valori CF, Ning K, Wyles M, Mead RJ, Grierson AJ, Shaw PJ, et al. Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy. Sci Transl Med. 2010;2:35ra42.","journal-title":"Sci Transl Med."},{"key":"338_CR41","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/hmg\/ddm379","volume":"17","author":"TO Gavrilina","year":"2008","unstructured":"Gavrilina TO, McGovern VL, Workman E, Crawford TO, Gogliotti RG, DiDonato CJ, et al. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle-specific SMN expression has no phenotypic effect. Hum Mol Genet. 2008;17:1063\u201375.","journal-title":"Hum Mol Genet."},{"key":"338_CR42","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1523\/JNEUROSCI.0204-12.2012","volume":"32","author":"TL Martinez","year":"2012","unstructured":"Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, Van Meerbeke JP, et al. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J Neurosci Off. J Soc Neurosci. 2012;32:8703\u201315.","journal-title":"J Soc Neurosci."},{"key":"338_CR43","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1523\/JNEUROSCI.5775-11.2012","volume":"32","author":"RG Gogliotti","year":"2012","unstructured":"Gogliotti RG, Quinlan KA, Barlow CB, Heier CR, Heckman CJ, DiDonato CJ. Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction. J Neurosci. 2012;32:3818\u201329.","journal-title":"J Neurosci."},{"key":"338_CR44","doi-asserted-by":"publisher","first-page":"e75866","DOI":"10.1371\/journal.pone.0075866","volume":"8","author":"X Paez-Colasante","year":"2013","unstructured":"Paez-Colasante X, Seaberg B, Martinez TL, Kong L, Sumner CJ, Rimer M. Improvement of neuromuscular synaptic phenotypes without enhanced survival and motor function in severe spinal muscular atrophy mice selectively rescued in motor neurons. PLoS ONE. 2013;8:e75866.","journal-title":"PLoS ONE."},{"key":"338_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-019-0318-4","volume":"14","author":"A Didonna","year":"2019","unstructured":"Didonna A, Opal P. The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders. Mol Neurodegener. 2019;14:19.","journal-title":"Mol Neurodegener."},{"key":"338_CR46","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0092-8674(92)90183-D","volume":"68","author":"SM de Waegh","year":"1992","unstructured":"de Waegh SM, Lee VM, Brady ST. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell. 1992;68:451\u201363.","journal-title":"Cell."},{"key":"338_CR47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrn2652","volume":"10","author":"SP Brooks","year":"2009","unstructured":"Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a user\u2019s guide. Nat Rev Neurosci. 2009;10:519\u201329.","journal-title":"Nat Rev Neurosci."},{"key":"338_CR48","first-page":"e006103","volume":"6","author":"PL Hess","year":"2017","unstructured":"Hess PL, Al\u2010Khalidi HR, Friedman DJ, Mulder H, Kucharska\u2010Newton A, Rosamond WR, et al. The metabolic syndrome and risk of sudden cardiac death: the atherosclerosis risk in communities study. J Am Heart Cardiovasc. 2017;6:e006103.","journal-title":"J Am Heart Cardiovasc."},{"key":"338_CR49","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41593-021-00827-3","volume":"24","author":"M Van Alstyne","year":"2021","unstructured":"Van Alstyne M, Tattoli I, Delestr\u00e9e N, Recinos Y, Workman E, Shihabuddin LS, et al. Gain of toxic function by long-term AAV9-mediated SMN overexpression in the sensorimotor circuit. Nat Neurosci. 2021;24:930\u201340.","journal-title":"Nat Neurosci."}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00338-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T09:09:16Z","timestamp":1664356156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["338"],"URL":"https:\/\/doi.org\/10.1038\/s41434-022-00338-1","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"21 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.K. received honoraria and travel accommodations from Roche as an invited speaker at their global and national board meetings in 2019. R.K. and the Ottawa Hospital Research Institute have a licensing agreement with Biogen for the <i>Smn<\/i><sup><i>2B\/\u2212<\/i><\/sup> mouse model. MOD received honoraria and travel accommodations from Biogen for speaking engagements at the SMA Summit 2018 held in Montreal, Canada and SMA Academy 2019 held in Toronto, Canada. These COIs are outside the scope of this study. All other authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}